Pregnant People Haven t Been Part Of Vaccine Trials Should They Get The Vaccine? – Nation & World News wuft.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wuft.org Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Silicon Therapeutics Announces Members of Scientific Advisory Board
December 10, 2020 GMT
BOSTON (BUSINESS WIRE) Dec 10, 2020
Silicon Therapeutics, a privately-held, integrated therapeutics company with a pioneering drug discovery platform based on physics-driven molecular simulations, today announced the members of the Silicon Therapeutics scientific advisory board (SAB), which include Dr. Elliot L. Chaikof, Dr. Timothy P. Heffernan, Dr. Sun Hur, Dr. Pasi A. Jänne and Dr. Lijun Sun.
ADVERTISEMENT
Silicon Therapeutics Scientific Advisory Board Member Elliot L. Chaikof, M.D., Ph.D.
The Silicon Therapeutics SAB is comprised of experts in biophysics, medicinal chemistry, translational medicine and research and development (R&D) in oncology and immunology. These experts will serve as a strategic resource for Silicon Therapeutics to provide scientific review and high-level advice about t
Silicon Therapeutics Announces Members of Scientific Advisory Board - Press Release digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
GenSight Biologics Announces Publication of Results from LUMEVOQ REVERSE Pivotal Phase III Trial and Non-Human Primate Study in Science Translational Medicine
Non-human primate study clarifies mechanism behind contralateral effect
Regulatory News:
GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the journal
Science Translational Medicine has published results from the REVERSE pivotal Phase III clinical trial of LUMEVOQ gene therapy in
ND4 Leber Hereditary Optic Neuropathy (LHON) subjects along with key results from a non-human primate study investigating the contralateral effect of the gene therapy. The paper , published in the December issue under the title Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary opt
Bernie Marcus, Arthur Blank transforming Atlanta health care with giving bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.